UNI-EN 10:Shares buy-back
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 10 | / | 2011 | | ||||||
| Date of issue: | 2011-12-06 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Shares buy-back | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Current report No. 9/2011 Dated December 6 2011 The Board of Directors of SOPHARMA AD (the “Company") hereby informs that from November 28 2011 up to and including December 1 2011 the Company bought 10 998 own shares representing 0.0083% of the share capital of the Company, to the total value of BGN 39 053.79 on the Bulgarian Stock Exchange. The average price per share was BGN 3.24. The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010. The intention of the Company is to use the repurchased shares in the future for the purpose of providing them to shareholders of companies targeted in mergers. The total number of own shares after these transactions is 2517356, representing 1.907% of the share capital of the Company. Legal grounds: Art. 56.1 of the Act on Public Offering, Conditions Governing the Introduction of Financial Instruments to Organized Trading, and Public Companies dated 29 July 2005. Signatures of individuals authorized to represent the Company Ognian Donev | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 10 buy back 06122011.doc Current report 10 buy back 06122011.doc | Shares buy-back report | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2011-12-06 | Ognian Donev | Executive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
